154 related articles for article (PubMed ID: 8735682)
1. Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
Combis JM; Vinel JP; Badia P; Barange K; Payen JL; Combis F; Desmorat H; Pascal JP
Br J Clin Pharmacol; 1996 May; 41(5):409-13. PubMed ID: 8735682
[TBL] [Abstract][Full Text] [Related]
2. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the effects of molsidomine and propranolol-molsidomine combination on portal hemodynamics by pulsed Doppler ultrasound].
Monnin JL; Vinel JP; Le Quellec A; Pascal JP; Taourel P; Bruel JM; Blanc F; Michel H; Ciurana AJ
Gastroenterol Clin Biol; 1992; 16(10):745-50. PubMed ID: 1478400
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic evaluation of molsidomine: a vasodilator with antianginal properties in patients with alcoholic cirrhosis.
Vinel JP; Monnin JL; Combis JM; Calés P; Desmorat H; Pascal JP
Hepatology; 1990 Feb; 11(2):239-42. PubMed ID: 2307402
[TBL] [Abstract][Full Text] [Related]
6. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
Hüppe D; Jäger D; Tromm A; Tunn S; Barmeyer J; May B
Dtsch Med Wochenschr; 1991 May; 116(22):841-5. PubMed ID: 2036943
[TBL] [Abstract][Full Text] [Related]
7. Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
Hadengue A; Moreau R; Cerini R; Koshy A; Lee SS; Lebrec D
Hepatology; 1989 Jan; 9(1):83-7. PubMed ID: 2908872
[TBL] [Abstract][Full Text] [Related]
8. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
[TBL] [Abstract][Full Text] [Related]
9. Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.
Ruiz del Arbol L; García-Pagán JC; Feu F; Pizcueta MP; Bosch J; Rodés J
J Hepatol; 1991 Sep; 13(2):179-86. PubMed ID: 1744422
[TBL] [Abstract][Full Text] [Related]
10. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
García-Pagán JC; Feu F; Bosch J; Rodés J
Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic effects of a combination of propranolol and clonidine in patients with post-hepatitic cirrhosis.
Lin HC; Tsai YT; Yang MC; Hou MC; Lee FY; Chen LS; Lee SD
J Gastroenterol Hepatol; 1995; 10(3):281-6. PubMed ID: 7548804
[TBL] [Abstract][Full Text] [Related]
13. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
[TBL] [Abstract][Full Text] [Related]
15. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of propranolol on portal venous pressure.
Garcia-Tsao G; Grace ND; Groszmann RJ; Conn HO; Bermann MM; Patrick MJ; Morse SS; Alberts JL
Hepatology; 1986; 6(1):101-6. PubMed ID: 3943775
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
[TBL] [Abstract][Full Text] [Related]
18. Clinical vs haemodynamic response to drugs in portal hypertension.
McCormick PA; Patch D; Greenslade L; Chin J; McIntyre N; Burroughs AK
J Hepatol; 1998 Jun; 28(6):1015-9. PubMed ID: 9672178
[TBL] [Abstract][Full Text] [Related]
19. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
[TBL] [Abstract][Full Text] [Related]
20. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
Hobolth L; Bendtsen F; Hansen EF; Møller S
Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
